Meaningful Use & the PHR Market

by | Jul 17, 2009

growthYesterday’s ONC HIT Policy Committee meeting was a big one.  Over the course of many hours, the committee went from hearing revised recommendations for Meaningful Use, to recommendations from the HIE workgroup and lastly recommendations regarding certification processes for EHRs.  Over the next week or so we plan to do separate write-ups on each of these topics and their implications.

ADDENDUM: HHS now has a webpage with links to various Meaningful Use documents and background pieces for you to drill down on.

But for today, one topic seems the most urgent and relevant to bring to the forefront (at least from our somewhat biased perspective) and that is…

What do the new meaningful use recommendations within the matrix (which was passed yesterday) mean to the PHR market?

Here is our quick sketch:

1) The topic of PHRs is embedded with the second priority of the meaningful use matrix, “Engage Patients & Families”.  Putting engagement of patients and families number 2 out of 5 signals that this is indeed important to this administration.  A very promising sign that tells the market that PHRs are, or at least will, become mainstream.

2) The revised matrix also accelerated the timetable for physician practices/hospitals to provide a patient with a PHR, populated in real-time with their personal health information (PHI) from 2015, to 2013.  Again, another sign that consumer access to PHI is not only critical to meaningful use (and critical to showing value to citizens that their tax dollars are going to something they may directly benefit from), but also critical to improving health and indeed doable.

3) With such emphasis on PHRs in this crucial set of recommendations that will define future HIT architectures for many years to come, PHRs will now have a front row seat at the CIO’s table and no longer simply be an afterthought.

4) While many EHR/EMR vendors will certainly attempt to sell their existing PHR solution to their prospects (most of these solutions are no more than a simple consumer portal into the EMR), most hospitals and physician networks do not have simple, single EHR vendor environments, e.g. New York Presbyterian’s partnership with Microsoft is a good example.  Thus, this creates an opportunity for independent PHR vendors with strong interoperability tools to step-up to the plate and serve this market opportunity.

5) This also creates an opportunity for independent PHR vendors to serve smaller specialty practices with solutions engineered to serve specific disease communities with a level of specificity not found in generic EMR/PHR solutions.  For example, one can envision a PHR for oncology practices that embeds rich functionality (CDS) and content that pertains to a given cancer condition and may even link-out to social communities such as LiveStrong.  As the market for PHRs expands and the population that can use them, naturally, the market also expands to address such niches in a profitable manner.  This will be the next evolution in the PHR market, but we are still at least 2-3 years away from this moving from trial stage to early adopter stage.

Heartening to see such high level support and committment to PHRs from HHS.  A market opportunity has been created and some PHR vendors are well-positioned to capitalize on it.  These may be quickly acquired by EMR vendors.  Others will successfully carve out a niche, but even here, they will need strong, or at least friendly partnerships with many a traditional HIT/EMR vendor.


  1. Carlos Leyva

    Yeah, there are lots of hidden “gems” in the final meaningful use definition.

    The PHR market will indeed takeoff but I can expect to see traction sooner than 2-3 years out. That is a lifetime in Internet time and the “big boys” are going to want to move much faster than that.

    • John

      Thanks for the comment Carlos and let me clarify. The 2-3 year time period refers to the development and early adopter use of disease specific PHRs, and not the more general, dare I say generic PHRs that are prevalent today.

  2. ahier

    Thanks for your usual excellent analysis John. Seems like a very good time be in the PR space. The surface hassbarely been scratched…

  3. Lincoln N.

    Disease specific applications for PHRs will be crucial if there is to be user adoption. The problem is that there are so many different PHR vendors out there in this fragmented market, with little utility to the end user.

  4. RememberItNow!

    I know my post is a little bit late, but just wanted to comment on your predictions about PHR’s now that Google is out of the picture.

    I agree with Lincoln’s comment about the market being so fragmented, but there are some PHR solutions that really do stand out from the rest.

    Take a look at ours at RememberItNow! we make eHealth easy. It’s all designed from the patient perspective and PC Mag said we were “Much easier to use and sleeker than Microsoft Health Vault and Google Health”

    Visit us:

    Alex Bettencourt



  1. ICMCC Website - Articles » Blog Archive » Meaningful Use & the PHR Market - [...] Article John Moore, Chilmark Research, 17 July 2009 SHARETHIS.addEntry({ title: "Meaningful Use & the PHR Market", url: "" });…
  2. ONC HIT Policy Committee Meeting | EMR and HIPAA - [...] Policy Committee meeting that happened on July 16, 2009 was a “big one” according to Chilmark Research. He said…
  3. Certified EHRs? What Are They Gets Defined Tomorrow « Chilmark Research - [...] the last HIT Policy Committee meeting on July 16th, the Meaningful Use workgroup presented the second iteration of their…
Submit a Comment

Your email address will not be published. Required fields are marked *

Related Content

Introducing the Health Impact Project

Introducing the Health Impact Project

The imperative for a new value assessment mindset in healthcare IT Early on in my taking the helm of Chilmark at the beginning of this year, it dawned on me how many new conversations I was seeing happen in the space about the difficulty assessing the value of IT in...

read more
A Redeterminations Disaster

A Redeterminations Disaster

The necessity of patient engagement with Carrie Kozlowski and Ed Marx In this episode of the Chilcast, Managing Partner John Moore is joined by Carrie Kozlowski, COO and co-founder of Upfront Healthcare, and Ed Marx, CEO and Founder of Marx Advisory and host of the...

read more
Powered By MemberPress WooCommerce Plus Integration